{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:26:52Z","timestamp":1776482812379,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T00:00:00Z","timestamp":1376611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2013.08.043","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T23:36:46Z","timestamp":1377646606000},"page":"4104-4110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes"],"prefix":"10.1016","volume":"32","author":[{"given":"Karine M.","family":"De Amicis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Freschi de Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel E.","family":"Alencar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edilberto","family":"Post\u00f3l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo de Oliveira","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen Andrade","family":"Arcuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibelly","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiza","family":"Guilherme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.043_bib0005","series-title":"Rheumatic fever","author":"Narula","year":"1999"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-2069.79617","article-title":"Autoimmunity and pathogenesis of rheumatic heart disease","volume":"4","author":"Guilherme","year":"2011","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"3 Suppl. 4","key":"10.1016\/j.vaccine.2013.08.043_bib0020","first-page":"1","article-title":"Diretrizes Brasileiras para Diagn\u00f3stico, Tratamento e Preven\u00e7\u00e3o da Febre Reum\u00e1tica da Sociedade Brasileira de Cardiologia, da Sociedade Brasileira de Pediatria e da Sociedade Brasileira de Reumatologia","volume":"93","author":"Barbosa","year":"2009","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2334-10-327","article-title":"Factors associated with Group A streptococcus emm type diversification in a large urban setting in Brazil: a cross-sectional study","volume":"10","author":"Tartof","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M protein: a highly versatile molecule","volume":"18","author":"Smeesters","year":"2010","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","article-title":"Molecular basis of group A streptococcal virulence","volume":"3","author":"Bisno","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0040","first-page":"222","article-title":"Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study","volume":"5","author":"McMillan","year":"2012","journal-title":"Authors Clin Microbiol Infec"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08916930500484674","article-title":"Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease","volume":"39","author":"Guilherme","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470-511.2000","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.CIR.92.3.415","article-title":"Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins","volume":"92","author":"Guilherme","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0065","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1586\/erv.09.133","article-title":"Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines","volume":"8","author":"Smeesters","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0070","series-title":"An update on Glomerulopathies \u2013 Clinical and Treatment Aspects","article-title":"S. Pyogenes infections and its sequelae","author":"Guilherme","year":"2011"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/599344","article-title":"Seven-year surveillance of North American pediatric group a streptococcal pharyngitis isolates","volume":"49","author":"Shulman","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0080","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1371\/journal.pone.0000010","article-title":"Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape","volume":"1","author":"Smeesters","year":"2006","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0085","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1128\/JB.186.13.4285-4294.2004","article-title":"Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures","volume":"186","author":"McGregor","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0090","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1086\/315842","article-title":"Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat","volume":"182","author":"Bessen","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0095","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/1469-0691.12134","article-title":"Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study","volume":"19","author":"McMillan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0100","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1016\/j.vaccine.2008.08.037","article-title":"Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development","volume":"26","author":"Smeesters","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/INF.0b013e318281da11","article-title":"Progress toward a global group a streptococcal vaccine","volume":"32","author":"Steer","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.08.043_bib0110","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: paving a path for accelerated development","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0115","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/QCO.0b013e328332bbfe","article-title":"Group A streptococcal vaccines: facts versus fantasy","volume":"22","author":"Steer","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17402520600877026","article-title":"Towards a vaccine against rheumatic fever","volume":"13","author":"Guilherme","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0130","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1074\/jbc.M110.132118","article-title":"Anti-group A streptococcal vaccine epitope: structure, stability, and its ability to interact with HLA class II molecules","volume":"286","author":"Guilherme","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0135","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymeth.2009.03.024","article-title":"A vaccine against S. pyogenes: design and experimental immune response","volume":"49","author":"Guilherme","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0140","doi-asserted-by":"crossref","first-page":"e60969","DOI":"10.1371\/journal.pone.0060969","article-title":"StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice","volume":"8","author":"Postol","year":"2013","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.vaccine.2013.08.043_bib0145","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1016\/j.vaccine.2011.08.113","article-title":"HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate","volume":"29","author":"Guerino","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0150","series-title":"S. pyogenes infection and it's sequelae","first-page":"468","author":"Guilherme","year":"2011"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0160","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0165","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.vaccine.2010.12.074","article-title":"Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells","volume":"29","author":"Goulart","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.043_bib0170","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.vaccine.2013.01.019","article-title":"Potential coverage of a multivalent M protein-based group A streptococcal vaccine","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T17:50:39Z","timestamp":1539453039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":34,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X13011341"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}